Computed Tomography (CT) Guided Lung Biopsy: Core or Fine Needle Aspiration
Not Applicable
Withdrawn
- Conditions
- Lung Cancer
- Registration Number
- NCT00188526
- Lead Sponsor
- University Health Network, Toronto
- Brief Summary
This study is a comparison of core needle biopsy with fine needle aspiration biopsy in the evaluation of lung nodules.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- All patients having a lung biopsy
Exclusion Criteria
- Lymphoma
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Diagnostic accuracy
- Secondary Outcome Measures
Name Time Method Complication rate
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular differences between core needle and fine needle aspiration biopsies in lung cancer diagnosis?
How does CT-guided core biopsy compare to fine needle aspiration in diagnosing non-small cell lung cancer (NSCLC)?
What biomarkers are most effectively detected via core needle biopsy versus fine needle aspiration in lung nodules?
What are the adverse event profiles associated with CT-guided core biopsy and fine needle aspiration in lung cancer patients?
Are there specific lung cancer subtypes where core biopsy provides superior diagnostic yield over fine needle aspiration?
Trial Locations
- Locations (1)
Toronto General Hospital
🇨🇦Toronto, Ontario, Canada
Toronto General Hospital🇨🇦Toronto, Ontario, Canada